VYNE Therapeutics Inc. ( VYNE) - Key Metrics
VYNE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q3 | $0 | -$0.17 | -$0.17 | -$0.17 |
| 2025Q2 | $0 | -$0.13 | -$0.25 | -$0.25 |
| 2025Q1 | $0 | -$0.20 | -$0.27 | -$0.27 |
VYNE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.28 |
| 2025Q3 | ? | -0.49 |
| 2025Q2 | ? | -3.06 |
| 2025Q1 | ? | -1.96 |
VYNE
Price: $0.51
52 week price:
Earnings Per Share: -0.51 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 68900
Market Capitalization: 11.3 million